Elekta AB Class B EBIT

Elekta AB Class B (EKTAF) currently reports a EBIT of $700M as of July 2026. That compares with $890M in the prior-year period — down 21.3% year over year. That is below the Healthcare sector average of $23B. Use the charts on this page to explore Elekta AB Class B's EBIT history and peer comparisons.

Elekta AB Class B's EBIT decreased from $890M to $700M — a 21.3% year-over-year decrease (period ending July 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Elekta AB Class B's EBIT of $700M is lower than the Healthcare sector average of $23B. That is roughly 96.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Elekta AB Class B reported $700M in EBIT as of July 2026. That compares with $890M in the prior-year period — down 21.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $700M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $23B. From there, open related valuation or income-statement pages for Elekta AB Class B, and consider following EKTAF for alerts when major investors trade the stock.